SS&C price target raised to $72 from $65 at RBC Capital

RBC Capital raised the firm’s price target on SS&C to $72 from $65 and keeps an Outperform rating on the shares after its Q4 earnings beat and guidance. The company’s 2024 feels like a “better jumping off point”, with organic growth set to improve, DomaniRX now launched, incremental cost savings from digital workers, and a highly variable rate balance sheet that should no longer be a major drag to earnings, the analyst tells investors in a research note.